← Back to Search

Psychotherapy

Psychotherapy for Postpartum Depression

N/A
Recruiting
Led By Nili Solomonov, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mini Mental Status Exam (MMSE) ≤ 1 SD below the mean score for patient's age and education
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a remote therapy called Engage & Connect for new mothers with postpartum depression. The therapy aims to reduce depression by encouraging social activities with significant others, helping mothers feel happier and less isolated.

Who is the study for?
This trial is for new mothers 4-12 weeks post-delivery who are experiencing postpartum depression, as indicated by a score of ≥10 on the Edinburgh Postnatal Depression Scale. Participants should be either off antidepressants or on a stable dose for at least 8 weeks and speak English well. Those with severe psychiatric conditions other than certain anxiety disorders or specific phobias, using certain psychotropic drugs, or undergoing ongoing psychotherapy are excluded.
What is being tested?
The study is testing 'Engage & Connect,' a new type of psychotherapy designed to help reduce postpartum depression. It involves 9 weeks of remote therapy sessions aimed at decreasing feelings of social isolation and improving how social rewards are processed, along with measuring changes in the severity of depression.
What are the potential side effects?
Since this trial involves psychotherapy rather than medication, traditional side effects associated with drugs may not apply. However, participants might experience emotional discomfort discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My mental function test score is slightly below average for my age and education.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, early treatment (week 3), mid-treatment (week 6) and post treatment (week 9) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Depression, Postpartum
Secondary study objectives
Mental Depression
Change in Social Reward Processing on STAR task

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Engage & ConnectExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,084 Previous Clinical Trials
1,138,839 Total Patients Enrolled
3 Trials studying Postpartum Depression
732 Patients Enrolled for Postpartum Depression
Nili Solomonov, PhDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
188 Total Patients Enrolled

Media Library

Engage & Connect (Psychotherapy) Clinical Trial Eligibility Overview. Trial Name: NCT05585164 — N/A
Postpartum Depression Research Study Groups: Engage & Connect
Postpartum Depression Clinical Trial 2023: Engage & Connect Highlights & Side Effects. Trial Name: NCT05585164 — N/A
Engage & Connect (Psychotherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05585164 — N/A
~13 spots leftby Jul 2025